Login Register Cart 0
Generic placeholder image

Current HIV Research

Editor-in-Chief

ISSN (Print): 1570-162X
ISSN (Online): 1873-4251

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Biography

Meet Our Editorial Board Member

Author(s): Siddappa N. Byrareddy

Volume 19, Issue 3, 2021

Published on: 01 April, 2021

Page: [199 - 200] Pages: 2

DOI: 10.2174/1570162X1903210401104648

Next »
[1]
Devadoss D, Singh SP, Acharya A, et al. HIV-1 productively infects and integrates in bronchial epithelial cells. Front Cell Infect Microbiol 2021; 10612360
[http://dx.doi.org/10.3389/fcimb.2020.612360 ] [PMID: 33614527]
[2]
Patel RH, Acharya A, Chand HS, Mohan M, Byrareddy SN. HIV and SARS-CoV-2 Co-infection: A systematic review of the literature and challenges. AIDS Res Hum Retroviruses 2021.
[http://dx.doi.org/10.1089/AID.2020.0284 ] [PMID: 33599163]
[3]
Acharya A, Olwenyi OA, Thurman M, et al. 2020.
[4]
Thurman M, Johnson S, Acharya A, Pallikkuth S, Mahesh M, Byrareddy SN. Biomarkers of activation and inflammation to track disparity in chronological and physiological age of people living with HIV on combination antiretroviral therapy. Front Immunol 2020; 11583934
[http://dx.doi.org/10.3389/fimmu.2020.583934 ] [PMID: 33162998]
[5]
Pandey K, Acharya A, Mohan M, Ng CL, Reid SP, Byrareddy SN. Animal models for SARS-CoV-2 research: A comprehensive literature review. Transbound Emerg Dis 2020.
[http://dx.doi.org/10.1111/tbed.13907 ] [PMID: 33128861]
[6]
Husain A, Byrareddy SN. Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19. Chem Biol Interact 2020; 331109282
[http://dx.doi.org/10.1016/j.cbi.2020.109282 ] [PMID: 33031791]
[7]
Singu S, Acharya A, Challagundla K, Byrareddy SN. Impact of social determinants of health on the emerging COVID-19 pandemic in the United States. Front Public Health 2020; 8: 406.
[http://dx.doi.org/10.3389/fpubh.2020.00406 ] [PMID: 32793544]
[8]
Olwenyi OA, Dyavar SR, Acharya A, et al. Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19). J Mol Med (Berl) 2020; 98(10): 1369-83.
[http://dx.doi.org/10.1007/s00109-020-01961-4 ] [PMID: 32808094]
[9]
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020; 109102433
[http://dx.doi.org/10.1016/j.jaut.2020.102433 ] [PMID: 32113704]
[10]
Trivedi J, Mahajan D, Jaffe RJ, Acharya A, Mitra D, Byrareddy SN. Recent advances in the development of integrase inhibitors for HIV treatment. Curr HIV/AIDS Rep 2020; 17(1): 63-75.
[http://dx.doi.org/10.1007/s11904-019-00480-3 ] [PMID: 31965427]
[11]
Routhu NK, Lehoux SD, Rouse EA, et al. Glycosylation of Zika Virus is important in host-virus interaction and pathogenic potential. Int J Mol Sci 2019; 20(20): 5206.
[http://dx.doi.org/10.3390/ijms20205206 ] [PMID: 31640124]
[12]
Zenere G, Olwenyi OA, Byrareddy SN, Braun SE. Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: A comprehensive review. Drug Discov Today 2019; 24(4): 983-91.
[http://dx.doi.org/10.1016/j.drudis.2019.02.002 ] [PMID: 30771481]
[13]
Namasivayam V, Vanangamudi M, Kramer VG, et al. The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic. J Med Chem 2019; 62(10): 4851-83.
[http://dx.doi.org/10.1021/acs.jmedchem.8b00843 ] [PMID: 30516990]
[14]
Bidokhti MRM, Dutta D, Madduri LSV, et al. SIV/SHIV-Zika co-infection does not alter disease pathogenesis in adult non-pregnant rhesus macaque model. PLoS Negl Trop Dis 2018; 12(10)e0006811
[http://dx.doi.org/10.1371/journal.pntd.0006811 ] [PMID: 30359380]
[15]
Routhu NK, Xie Y, Dunworth M, Casero RA Jr, Oupicky D, Byrareddy SN. Polymeric Prodrugs Targeting Polyamine Metabolism Inhibit Zika Virus Replication. Mol Pharm 2018; 15(9): 4284-95.
[http://dx.doi.org/10.1021/acs.molpharmaceut.8b00068 ] [PMID: 30040423]
[16]
Dutta D, Johnson S, Dalal A, Deymier MJ, Hunter E, Byrareddy SN. High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses. PLoS One 2018; 13(5)e0196942
[http://dx.doi.org/10.1371/journal.pone.0196942 ] [PMID: 29758076]
[17]
Gumber S, Amancha PK, Yen PJ, Villinger F, Gabuzda D, Byrareddy SN. In vivo characterization of macrophage-tropic simian immunodeficiency virus molecular clones in rhesus macaques. J Neurovirol 2018; 24(4): 411-9.
[http://dx.doi.org/10.1007/s13365-018-0628-2 ] [PMID: 29594984]
[18]
Santangelo PJ, Cicala C, Byrareddy SN, et al. Early Treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection. Mucosal Immunol 2018; 11(3): 932-46.
[http://dx.doi.org/10.1038/mi.2017.112 ] [PMID: 29346349]
[19]
Arthos J, Cicala C, Nawaz F, et al. The Role of Integrin α4β7 in HIV Pathogenesis and Treatment. Curr HIV/AIDS Rep 2018; 15(2): 127-35.
[http://dx.doi.org/10.1007/s11904-018-0382-3 ] [PMID: 29478152]
[20]
Micci L, Ryan ES, Fromentin R, et al. Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques. J Clin Invest 2015; 125(12): 4497-513.
[http://dx.doi.org/10.1172/JCI81400 ] [PMID: 26551680]
[21]
Byrareddy SN, Sidell N, Arthos J, et al. Species-specific differences in the expression and regulation of α4β7 integrin in various nonhuman primates. J Immunol 2015; 194(12): 5968-79.
[http://dx.doi.org/10.4049/jimmunol.1402866 ] [PMID: 25948815]
[22]
Santangelo PJ, Rogers KA, Zurla C, et al. Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques. Nat Methods 2015; 12(5): 427-32.
[http://dx.doi.org/10.1038/nmeth.3320 ] [PMID: 25751144]
[23]
Byrareddy SN, Kallam B, Arthos J, et al. Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection. Nat Med 2014; 20(12): 1397-400.
[http://dx.doi.org/10.1038/nm.3715 ] [PMID: 25419708]
[24]
Takahashi Y, Byrareddy SN, Albrecht C, et al. In vivo administration of a JAK3 inhibitor during acute SIV infection leads to significant increases in viral load during chronic infection. PLoS Pathog 2014; 10(3)e1003929
[http://dx.doi.org/10.1371/journal.ppat.1003929 ] [PMID: 24603870]
[25]
Byrareddy SN, Ayash-Rashkovsky M, Kramer VG, et al. Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques. PLoS One 2013; 8(9)e75556
[http://dx.doi.org/10.1371/journal.pone.0075556 ] [PMID: 24098702]

Rights & Permissions Print Cite
Article Metrics
11
World Immunization Week
© 2024 Bentham Science Publishers | Privacy Policy